Periorbital Placement of a Laser Doppler Probe for Cerebral Blood Flow Monitoring Prior to Middle Cerebral Artery Occlusion in Rodent Models
November 22nd, 2024
A minimally invasive surgical procedure is shown here, which involves placing the laser Doppler probe onto the skull over the distal region of the middle cerebral artery (MCA), a periorbital location suitable for rats and mice, to assess blood flow during transient MCA occlusion.
I investigated ischemic stroke, focusing on microglia, reperfusion injury, and sex differences in the brain. My work aims to understand how these factors affect brain injury and to develop targeted treatments for improved stroke treatments at acute and chronic timelines. Reproducibility and sample size are key challenges in stroke research.
Variability in injury size from the middle cerebral artery occlusion procedure often requires larger sample sizes for accurate statistical testing, which may be underrecognized and impact reproducibility of science in our field. Our most significant findings and contributions revolve around microglia quantifications and the intersection with ischemic stroke from an acute and chronic perspective. Using Laser Doppler flowmetry in MCAO can be challenging, especially in rats due to thicker skulls and the perception that skull thinning and specialized equipment for dorsal probe placement are needed.
These barriers may hinder LDF implementation for confirming filament placement. The protocol outlines placing the Laser Doppler probe at the skull in distal middle cerebral artery region periorbital placement to assess blood flow during MCAO in mice and rats. It offers advantages over other methods by being minimally invasive, fast, and requiring only the Laser Doppler probe.
Overview
This study focuses on ischemic stroke, investigating the role of microglia, reperfusion injury, and sex differences in the brain. A minimally invasive surgical procedure is employed using a laser Doppler probe placed over the distal middle cerebral artery region in rats and mice to assess blood flow during transient MCA occlusion.
Key Study Components
Area of Science
- Neuroscience
- Stroke Research
- Microglial Dynamics
Background
- Ischemic stroke is a major cause of brain injury.
- Microglia play a crucial role in response to ischemic conditions.
- Variability in injury size necessitates larger sample sizes for statistical accuracy.
- This study addresses critical challenges in reproducibility in stroke research.
Purpose of Study
- To understand the impact of microglia on brain injury from ischemic stroke.
- To investigate sex differences in stroke outcomes.
- To develop targeted treatments for acute and chronic stroke.
Methods Used
- The main platform involves laser Doppler flowmetry for assessing blood flow.
- The biological model consists of rats and mice undergoing transient MCA occlusion.
- No multiomics workflow is mentioned in the text.
- The Laser Doppler probe is placed at a specific location on the skull for optimal results.
- The method is noted for being minimally invasive and quick.
Main Results
- The study reveals significant findings regarding microglial quantifications in response to acute and chronic ischemic stroke.
- Challenges with laser Doppler flowmetry in rats due to skull thickness are highlighted.
- Findings indicate variability in injury response necessitates larger sample sizes for reproducibility.
- The study validates the advantages of the minimally invasive approach for blood flow assessment.
Conclusions
- This study demonstrates the feasibility of using laser Doppler flowmetry in stroke research.
- It provides insights into microglial roles in ischemic stroke, facilitating the development of targeted therapies.
- Implications for understanding neuronal mechanisms and addressing challenges in stroke research are significant.
Frequently Asked Questions
Executive Industry Relevance
Reliable cerebral blood flow (CBF) monitoring is critical for preclinical ischemic stroke models, directly impacting target validation and reproducibility in neurovascular drug discovery. The periorbital placement of a laser Doppler probe streamlines CBF assessment during middle cerebral artery occlusion (MCAO), reducing technical barriers and variability. This approach enhances predictive confidence at the discovery and preclinical inflection points, supporting robust portfolio advancement decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables real-time confirmation of MCAO success, reducing false negatives in target validation studies.
- Improves biological de-risking by minimizing procedural variability in ischemic injury models.
- Supports predictive confidence for mechanistic studies involving neuroinflammation and reperfusion injury.
Screening & Assay Development
- Facilitates standardized preparation of disease-relevant rodent models for downstream compound screening.
- Provides quantitative CBF readouts, supporting assay reproducibility and cross-study comparability.
- Streamlines workflow by eliminating skull thinning and specialized equipment requirements.
Translational & Preclinical Research
- Aligns preclinical models with translational endpoints by ensuring consistent ischemic insult across cohorts.
- Enables risk-adjusted advancement of neuroprotective and anti-inflammatory candidates.
- Supports continuity from discovery through preclinical validation by improving model reliability.
Pipeline & Workflow Integration
This technique integrates at the interface of early discovery and preclinical validation, providing a reproducible foundation for lead identification and mechanistic de-risking in neurovascular research.
- Discovery Biology: Confirms successful MCAO induction, supporting hypothesis testing and pathway interrogation.
- Screening: Delivers quantitative CBF metrics for assay readiness and reproducibility.
- Analytics: Enables statistical comparison of injury severity and intervention effects across experimental arms.
- Translational Research: Enhances model fidelity for biomarker alignment and translational continuity.
- Enterprise Reuse: Offers a scalable, minimally invasive protocol adaptable across rodent models and research teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in stroke models.
- Operational Value: Promotes standardization, reproducibility, and efficiency in preclinical workflows.
- Strategic Value: Supports robust go/no-go decisions and capital-efficient portfolio progression.
- Portfolio Impact: Enables risk-adjusted prioritization of neurovascular targets and therapeutic candidates.
Implementation Considerations
- Requires expertise in rodent surgical techniques and CBF monitoring.
- Needs access to laser Doppler flowmetry instrumentation and compatible probes.
- Demands cross-team standardization of probe placement and data interpretation.
- Adaptable to both mice and rats, with consideration for anatomical differences.
- Potential limitations include probe placement variability and species-specific skull thickness.
